CCL2 and breast cancer: While the control group generally exhibited low baseline levels of circulating cytokines, breast cancer patients demonstrated significantly elevated concentrations of multiple cytokines, including IL-1β, IL-6, IL-8, IL-12 (p40), IL-13, G-CSF, TNF-α, and MCP-1.